Alka Chaubey - Feb 15, 2025 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Chief Medical Officer
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Stock symbol
BNGO
Transactions as of
Feb 15, 2025
Transactions value $
-$103
Form type
4
Date filed
2/19/2025, 06:56 PM
Previous filing
Sep 13, 2024
Next filing
Mar 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Tax liability -$103 -18 -2.38% $5.73 737 Feb 15, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is reporting the withholding by the Issuer of an aggregate of 18 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.
F2 On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 44,568 less shares of common stock.